Analysis of anticancer drugs using thin layer chromatography– A review

Abstract

Cancer is a fatal disease and cancer incidence is increasing from day to day. Thus, anticancer drugs are widely used and their analysis requires simple and effective analytical procedures. Thin layer chromatography (TLC) is a promising technique for drug analysis as a simple and versatile technique with low cost of analysis, minimal sample clean-up and high sample loading capacity. An extensive literature survey has been done and TLC techniques used for the analysis of anticancer agents in different matrices have been presented.

Keywords

• Thin layer chromatography
• anticancer drugs
• biological fluids
• pharmaceuticals
• plants

References

1. [1] Shewach DS, Kuchta RD. Introduction to cancer chemotherapeutics. Chem Rev. 2009; 109(7): 2859-2861. [CrossRef]
2. [2] Thurston DE. Chemistry and Pharmacology of Anticancer Drugs, first ed., CRC Press, Taylor and Francis Group, Boca Raton 2007.
3. [3] Linda L. Pharmaceuticals and drugs: Guidelines for analysis. In: Sherma J, Fried B. (Eds). Handbook of thin-layer chromatography. Marcel Dekker, New York, 1991, pp. 717-755.
4. [4] Sherma J. Review of HPTLC in drug analysis: 1996-2009. J AOAC Int. 2010; 93(3): 754-764.
5. [5] Sherma J. Planar chromatography. Anal Chem. 2010; 82(12): 4895-4910. [CrossRef]
6. [6] Sherma J. Biennial review of planar chromatography: 2011-2013. Cent Eur J Chem. 2014; 12(4): 427-452. [CrossRef]
7. [7] Sherma J. Biennial review of planar chromatography: 2013-2015. J AOAC Int. 2016; 99(2): 323-331. [CrossRef]
8. [8] Nussbaumer S, Bonnabry P, Veuthey JL, Fleury-Souverain S. Analysis of anticancer drugs: A review. Talanta. 2011; 85(5): 2265-2289. [CrossRef]

9. [9] Yeniceli D. Thin-layer chromatography of anticancer drugs. In: Komsta L, Waksmundzka-Hajnos M, Sherma J. (Eds). Thin Layer Chromatography in Drug Analysis. CRC Press, Taylor and Francis Group, Boca Raton, FL, 2013, pp. 995-1008.
10. [10] Perello L, Demirdjian S, Dory A, Bourget P. Application of high-performance, thin-layer chromatography to quality control of antimetabolite analogue infusion bags. J AOAC Int. 2001; 84(4): 1296-1300.
11. [11] Paci A, Mercier L, Bourget P. Identification and quantitation of antineoplastic compounds in chemotherapeutic infusion bags by use of HPTLC: application to the vinca-alkaloids. J Pharm Biomed Anal. 2003; 30(5): 1603-1610. [CrossRef]
12. [12] Bouligand J, Paci A, Mercier L, Vassal G, Bourget P. High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and quantitation of busulfan in various pharmaceutical products. J Pharm Biomed Anal. 2004; 34(3): 525-530. [CrossRef]
13. [13] Bouligand J, Storme T, Laville I, Mercier L, Oberlin O, Vassal G, Bourget P, Paci A. Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products. J Pharm Biomed Anal. 2005; 38(1): 180-185. [CrossRef]
14. [14] Gravel E, Bourget P, Mercier L, Paci A. Fluorescence detection combined with either HPLC or HPTLC for pharmaceutical quality control in a hospital chemotherapy production unit: Application to camptothecin derivatives. J Pharm Biomed Anal. 2005; 39(3-4): 581-586. [CrossRef]
15. [15] Bourget P, Paci A, Rey JB, Mercier L, Demirdjian S. Contribution of high-performance thin-layer chromatography to a pharmaceutical quality assurance programme in a hospital chemotherapy manufacturing unit. Eur J Pharm Biopharm. 2003; 56(3): 445-451. [CrossRef]
16. [16] Nowakowska J, Pikul P, Rogulski P. TLC of aclarubicin and doxycycline with mixed n-alcohol mobile phases. J Planar Chromatogr. 2010; 23(5): 353-358. [CrossRef]
17. [17] Vadera N, Subramanian G, Musmade P. Stability-indicating HPTLC determination of imatinib mesylate in bulk drug and pharmaceutical dosage form. J Pharm Biomed Anal. 2007; 43(2): 722-726. [CrossRef]
18. [18] Mhaske DV, Dhaneshwar SR. Stability indicating HPTLC and LC determination of dasatinib in pharmaceutical dosage form. Chromatographia. 2007; 66(1-2): 95-102. [CrossRef]
19. [19] Akhtar N, Talegaonkar S, Khar RK, Faiyazuddin MD, Ahmad FJ, Iqbal Z, Jaggi M. A stability indicating HPTLC method for the analysis of irinotecan in bulk drug and marketed injectables. J Liq Chromatogr Relat Technol. 2011; 34(14): 1459-1472. [CrossRef]
20. [20] Borisagar SL, Patel HU, Patel CN. A validated stability-indicating HPTLC method for the estimation of gemcitabine HCI in its dosage form. J Planar Chromatogr. 2012; 25(1): 77-80. [CrossRef]
21. [21] Bharati P, Vinodini A, Reddy AS, Devi PS. Development and validation of a planar chromatographic method with reflectance scanning densitometry for quantitative analysis of anastrozole in the bulk material and in tablet formulations. J Planar Chromatogr. 2010; 23(1): 79-83. [CrossRef]
22. [22] Jamshidi A, Mobedi H, Ahmad-Khanbeigi F. Stability-indicating HPTLC assay for leuprolide acetate. J Planar Chromatogr. 2006; 19(109): 223-227. [CrossRef]
23. [23] Kulkarni S, Chitalkar K, Shinde N, Tekale P, Lanjewar R. A validated high-performance thin-layer chromatographic method for the determination of azathioprine from pharmaceutical formulation. J Planar Chromatogr. 2014; 27(2): 120-123. [CrossRef]
24. [24] Sharma S, Sharma MC. Development and validation of spectrophotometric method and TLC densitometric determination of irinotecan HCl in pharmaceutical dosage forms. Arab J Chem. 2012; 9: 1368-1372. [CrossRef]
25. [25] Jamshidi A, Sharifi S. HPTLC analysis of tamoxifen citrate in drug-release media during development of an in-situ cross-linking delivery system. J Planar Chromatogr. 2009; 22(3): 187-189. [CrossRef]
26. [26] Subramanian GS, Karthik A, Baliga A, Musmade P, Kini S. High-performance thin-layer chromatographic analysis of bicalutamide in bulk drug and liposomes. J Planar Chromatogr. 2009; 22(4): 273-276. [CrossRef]
27. [27] Saetern AM, Skar M, Braaten A, Brandl M. Camptothecin-catalyzed phospholipid hydrolysis in liposomes. Int J Pharm. 2005; 288(1): 73-80. [CrossRef]
28. [28] Tazina EV, Ignatieva EV, Polozkova AP, Oborotova NA. Qualitative and quantitative analysis of thermosensitive liposomes loaded with doxorubicin. Pharm Chem J. 2012; 46(1): 54-59. [CrossRef]
29. [29] Agrawal V, Paul MK, Mukhopadhyay AK. 6-Mercaptopurine and daunorubicin double drug liposomes—preparation, drug-drug interaction and characterization. J Liposome Res. 2005; 15(3-4): 141-155. [CrossRef]
30. [30] The European Pharmacopoeia. Editions du Conseil de l’Europe, seventh ed., Strasbourg, France, 2011.
31. [31] The British Pharmacopoeia. HMSO: London, 1993.
32. [32] The United States Pharmacopeia. Rockville, MD, USA, 2006.
33. [33] Aboul-Enein HY, El-Awady MI, Heard CM, Nicholls PJ. Application of thin-layer chromatography in enantiomeric chiral analysis - an overview. Biomed Chromatogr. 1999; 13(8): 531-537. [CrossRef]
34. [34] Del Bubba M, Checchini L, Lepri L. Thin-layer chromatography enantioseparations on chiral stationary phases: a review. Anal Bioanal Chem. 2013; 405: 533–554. [CrossRef]
35. [35] Mane S. Racemic drug resolution: a comprehensive guide. Anal Methods. 2016; 8: 7567-7586. [CrossRef]
36. [36] Lepri L, Coas V, Desideri PG, Zocchi A. Reversed phase planar chromatography of enantiomeric compounds on triacetylcellulose. J Planar Chromatogr. 1994; 7(5): 376-381.
37. [37] Lepri L. Enantiomer separation by TLC. J Planar Chromatogr. 1997; 10(5): 320-331.
38. [38] Aboul-Enein HY, El-Awady MI, Heard CM. Enantiomeric separation of aminoglutethimide, acetylaminoglutethimide, and dansylaminoglutethimide by TLC with β-cyclodextrin and derivatives as mobile phase additives. J Liq Chromatogr Relat Technol. 2000; 23(17): 2715-2726. [CrossRef]
39. [39] Baumann F, Preiss R. Cyclophosphamide and related anticancer drugs. J Chromatogr B. 2001; 764(1-2): 173-192. [CrossRef]
40. [40] Peng SX. Separation and identification methods for metalloproteinase inhibitors. J Chromatogr B. 2001; 764(1-2): 59-80. [CrossRef]
41. [41] Loadman PM, Calabrese CR. Separation methods for anthraquinone related anti-cancer drugs. J Chromatogr B. 2001; 764(1-2): 193-206. [CrossRef]
42. [42] Paci A, Rieutord A, Brion F, Prognon P. Separation methods for alkylating antineoplastic compounds. J Chromatogr B. 2001; 764(1-2): 255-287. [CrossRef]
43. [43] Khuhawar MY, Qureshi GA. Polyamines as cancer markers: applicable separation methods. J Chromatogr B. 2001; 764(1-2): 385-407. [CrossRef]
44. [44] Tasso MJ, Boddy AV, Price L, Wyllie RA, Pearson AD, Idle JR. Pharmacokinetics and metabolism of cyclophosphamide in pediatric-patients. Cancer Chemother Pharmacol. 1992; 30(3): 207-211. [CrossRef]
45. [45] Yule SM, Boddy AV, Cole M, Price L, Wyllie RA, Tasso MJ, Pearson AD, Idle JR. Cyclophosphamide metabolism in children. Cancer Res. 1995; 55(4): 803-809.
46. [46] Boddy AV, Idle JR. Combined thin-layer chromatography-photography-densitometry for the quantification of ifosfamide and its principal metabolites in urine, cerebrospinal fluid and plasma. J Chromatogr Biomed Appl. 1992; 575(1): 137-142. [CrossRef]
47. [47] Boddy AV, Yule SM, Wyllie R, Price L, Pearson AD, Idle JR. Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children. Cancer Res. 1993; 53(16): 3758-3764.
48. [48] Boddy AV, Proctor M, Simmonds D, Lind MJ, Idle JR. Pharmacokinetics, metabolism and clinical effect of ifosfamide in breast cancer patients. Eur J Cancer. 1995; 31(1): 69-76. [CrossRef]
49. [49] Koskinen M, Rajaniemi H, Hemminki K. Analysis of tamoxifen-induced DNA adducts by 32P-postlabelling assay using different chromatographic techniques. J Chromatogr B. 1997; 691(1): 155-160. [CrossRef]
50. [50] Vicario A, Sergo V, Toffoli G, Bonifacio A. Surface-enhanced Raman spectroscopy of the anti-cancer drug irinotecan in presence of human serum albumin. Colloids Surf B-Biointerfaces. 2015; 127: 41–46. [CrossRef]
51. [51] Bhusari P, Vatsa R, Singh G, Dhawan DK, Shukla J, Mittal BR. Development and characterization of DTPA-trastuzumab conjugates for radiolabeling with Tc-99m: A radiopharmaceutical for HER2/neu breast cancer. J Drug Deliv Sci Technol. 2015; 29: 8-15. [CrossRef]
52. [52] Banerjee I, Behera A, De K, Chattopadhyay S, Sachdev SS, Sarkar B, Ganguly S, Misra M. Synthesis, characterization, biodistribution and scintigraphy of 99mTc-paclitaxel: a potential tracer of paclitaxel. J Radioanal Nucl Chem. 2014; 304: 633–643. [CrossRef]
53. [53] Monteiro LOF, Fernandes RS, Castro LC, Cardoso VN, Oliveira MC, Townsend DM, Ferretti A, Rubello D, Leite EA, de Barros ALB. Technetium-99m radiolabeled paclitaxel as an imaging probe for breast cancer in vivo. Biomed Pharmacother. 2017; 89: 146–151. [CrossRef]
54. [54] Paw B, Misztal G. Thin-layer chromatographic analysis of antimetabolites of pyrimidine bases in human plasma. Chem Anal. 1997; 42(1): 37-40.
55. [55] Fung LK, Ewend MG, Sills A, Sipos EP, Thompson R, Watts M, Colvin OM, Brem H, Saltzman WM. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res. 1998; 58(4): 672-684.
56. [56] Itokawa H, Lee KH. Taxus: The Genus Taxus, first ed., CRC Press, Taylor and Francis Group, Boca Raton, FL, 2003.
57. [57] Hajnos ML. TLC of Diterpenes. In: Waksmundzka-Hajnos M, Sherma J, Kowalska T. (Eds). Thin Layer Chromatography in Phytochemistry. CRC Press, Taylor and Francis Group, Boca Raton, FL, 2008, pp. 481-517.
58. [58] Glowniak K, Wawrynowicz T, Hajnos M. The application of zonal thin-layer chromatography to the determination of paclitaxel and 10-deacetylbaccatin III in some Taxus species. J Planar Chromatogr. 1999; 12(5): 328-335.
59. [59] Hajnos ML, Glowniak K, Waksmundzka-Hajnos M, Kogut P. Optimization of the isolation of some taxoids from yew tissues. J Planar Chromatogr. 2001; 14(2): 119-125.
60. [60] Hajnos ML, Waksmundzka-Hajnos M, Gawdzik J, Dawidowicz AL, Glowniak K. Influence of the extraction mode on the yield of taxoids from yew tissues - preliminary experiments. Chem Anal. 2001; 46(6): 831-838.
61. [61] Hajnos ML, Glowniak K, Waksmundzka-Hajnos M, Piasecka S. Application of pseudo-reversed-phase systems to the purification and isolation of biologically active taxoids from plant material. Chromatographia. 2002; 56: 91-94. [CrossRef]
62. [62] Migas P, Switka M. TLC with an adsorbent gradient for the analysis of taxol in Taxus baccata L. J Planar Chromatogr. 2010; 23(4): 286-288. [CrossRef]
63. [63] Wang JF, Li GL, Lu HY, Zheng ZH, Huang XJ, Su WJ. Taxol from Tubercularia sp strain TF5, an endophytic fungus of Taxus mairei. FEMS Microbiol Lett. 2000; 193(2): 249-253. [CrossRef]
64. [64] Sreekanth D, Syed A, Sarkar S, Sarkar D, Santhakumari B, Ahmad A, Khan MI. Production, purification, and characterization of taxol and 10-DABIII from a new endophytic fungus Gliocladium sp. isolated from the Indian yew tree, Taxus baccata. J Microbiol Biotechnol. 2009; 19(11): 1342-1347. [CrossRef]
65. [65] Zocher R, Weckwerth W, Hacker C, Kammer B, Hornbogen T, Ewald D. Biosynthesis of taxol: Enzymatic acetylation of 10-deacetylbaccatin-III to baccatin-III in crude extracts from roots of Taxus baccata. Biochem Biophys Res Commun. 1996; 229(1): 16-20. [CrossRef]
66. [66] Glowniak K, Mroczek T. Investigations on preparative thin-layer chromatographic separations of taxoids from Taxus Baccata L. J Liq Chromatogr Relat Technol. 1999; 22(16): 2483-2502. [CrossRef]
67. [67] Glowniak K, Zgorka G, Jozefczyk A, Furmanowa M. Sample preparation for taxol and cephalomannine determination in various organs of Taxus sp. J Pharm Biomed Anal. 1996; 14(8-10): 1215-1220. [CrossRef]
68. [68] Matysik G, Glowniak K, Jozefczyk A, Furmanowa M. Stepwise gradient thin-layer chromatography and densitometric determination of taxol in extracts from various species of Taxus. Chromatographia. 1995; 41(5-6): 485-487.
69. [69] Srinivasan V, Roberts SC, Shuler ML. Combined use of six-well polystyrene plates and thin layer chromatography for rapid development of optimal plant cell culture processes: application to taxane production by Taxus sp. Plant Cell Rep. 1997; 16(9): 600-604.
70. [70] Das K, Dang R, Ghanshala N, Rajasekharan PE. Phytochemical investigations of in vitro propagated plant Taxus wallichiana Zucc. An endangered anticancer medicinal plant of Indian origin. Ann Phytomed. 2015; 4(2): 59-66.
71. [71] Wang S, Li C, Wang H, Zhong X, Zhao J, Zhou Y. A process optimization study on ultrasonic extraction of paclitaxel from Taxus cuspidata. Prep Biochem Biotechnol. 2016; 46(3): 274-280. [CrossRef]
72. [72] Dighe V, Sane RT, Parekh G, Gokarn V, Dhotre O. HPTLC quantitation of camptothecin in Nothapodytes foetida (Wight) Sleumer stem powder. J Planar Chromatogr. 2007; 20(2): 131-133. [CrossRef]
73. [73] Mishra N, Acharya R, Gupta AP, Singh B, Kaul VK, Ahuja PS. A simple microanalytical technique for determination of podophyllotoxin in Podophyllum hexandrum roots by quantitative RP-HPLC and RP-HPTLC. Curr Sci. 2005; 88(9): 1372-1373.
74. [74] Namdeo AG, Sharma A, Sathiyanarayanan L, Fulzele D, Mahadik KR. HPTLC densitometric evaluation of tissue culture extracts of Nothapodytes foetida compared to conventional extracts for camptothecin content and antimicrobial activity. Planta Med. 2010; 76(5): 474-480. [CrossRef]
75. [75] Ahmad R, Sharma VK, Rai AK, Shivananda RD, Shivananda BG. Production of lignans in callus culture of Podophyllum hexandrum. Trop J Pharm Res. 2007; 6(4): 803-808. [CrossRef]
76. [76] Kumar A, Patil D, Rajamohanan PR, Ahmad A. Isolation, purification and characterization of vinblastine and vincristine from endophytic fungus Fusarium oxysporum isolated from Catharanthus roseus. Plos One. 2013; 8(9): 1-10. [CrossRef]
77. [77] Ran XQ, Zhang G, Li S, Wang JF. Characterization and antitumor activity of camptothecin from endophytic fungus Fusarium solani isolated from Camptotheca acuminata. Afr Health Sci. 2017; 17(2): 566-574. [CrossRef]
78. [78] Kumar A, Ahmad A. Biotransformation of vinblastine to vincristine by the endophytic fungus Fusarium oxysporum isolated from Catharanthus roseus. Biocatal Biotransfor. 2013; 31(2): 89–93. [CrossRef]
79. [79] Chunfang Z, Yin X, Longjiang Y, Shuo L, Zeqiang W. TLC and HPLC methods to follow the synthesis of vinorelbine. J Chromatogr Sci. 2010; 48(8): 685-689. [CrossRef]
80. [80] Khabiya R, Upadhyay D, Srivastava A, Anandjiwala S. Simultaneous quantification of three bioactive lignans, viz., phyllanthin, hypophyllanthin, and niranthin from Phyllanthus amarus using high-performance thin-layer chromatography. J Planar Chromatogr. 2014; 27(4): 281-286. [CrossRef]
81. [81] Ciura K, Dziomba S, Nowakowska J, Markuszewski MJ. Thin layer chromatography in drug discovery process. J Chromatogr A. 2017; 1520: 9-22. [CrossRef]
82. [82] Wicha-Komsta K, Komsta L. Unconventional TLC systems in lipophilicity determination: A review. J Liq Chromatogr Relat Technol. 2017; 40(5-6): 219-225. [CrossRef]
83. [83] Bajda M, Boryczka S, Wietrzyk J, Malawska B. Investigation of lipophilicity of anticancer-active thioquinoline derivatives. Biomed Chromatogr. 2007; 21(2): 123-131. [CrossRef]
84. [84] Perisic-Janjic N, Djakovic-Sekulic T, Stojanovic S, Penov-Gasi K. Evaluation of the lipophilicity of some dehydroepiandrosterone derivatives using RP-18 HPTLC chromatography. Chromatographia. 2004; 60(Suppl 1): 201-205. [CrossRef]
85. [85] Perisic-Janjic NU, Djakovic-Sekulic TL, Stojanovic SZ, Penov-Gasi K. HPTLC chromatography of androstene derivatives. Application of normal phase thin-layer chromatographic retention data in QSAR studies. Steroids. 2005; 70(3): 137-144. [CrossRef]
86. [86] Czyrski A, Kupczyk B. The determination of partition coefficient of 6-Mercaptopurine derivatives by Thin Layer Chromatography. J Chem. 2013; 2013: 1-4. [CrossRef]
87. [87] Kowalska A, Pluta K. RP TLC assay of the lipophilicity of new azathioprine analogs. J Liq Chromatogr Relat Technol. 2012; 35(12): 1686-1696. [CrossRef]
88. [88] Sochacka J, Kowalska A. Comparison of calculated values of the lipophilicity of 2,6-disubstituted 7-methyl purines with values determined by RPTLC. J Planar Chromatogr. 2006; 19(110): 307-312. [CrossRef]